Non-viral gene vectors
Gene-Enhanced Personalized Regenerative Medicine for Bone
... local gene therapy in ...vivo gene therapy is safer and more helpful; because genetic manipulations get done outside the ...14 Viral and non-viral vectors can be used in ...
5
Improved osteogenic vector for non-viral gene therapy
... of gene therapy encoding an exogenous gene on a plasmid (Feichtinger et ...alternative, gene therapy allows local and sustained release of growth ...of gene therapy in order to stimulate bone ...
14
The emerging role of viral vectors as vehicles for DMD gene editing
... different gene-editing re- agents and strategies for developing autologous cell transplantation ...different gene-editing tools into human muscle progenitor cells and non-muscle cells with myogenic ...
10
Recent advances in the development of gene delivery systems
... Non-viral gene delivery mediated artificially by phys- ical method uses to introduce genetic materials through the cell ...of gene deliv- ery includes needle injection, ballistic DNA ...
7
Gene Therapy, Early Promises, Subsequent Problems, and Recent Breakthroughs
... Lentiviral vectors are based on human immunodeficiency virus-1 (HIV-1), non-human immunodeficiency (SIV), or feline immunodeficiency ...Lentiviral Vectors are efficient and stable gene ...
7
THE USE OF VIRAL VECTORS IN GENE TRANSFER THERAPY
... replication-deficient non-enveloped ...a non- pathogenic DNA virus used as a vector for transport of eukaryotic genes in vitro and in ...AAV vectors can show relative preference to actively dividing ...
6
Meyer, Martin (2009): Dynamic endosomolytic polymer conjugates for pDNA and siRNA delivery. Dissertation, LMU München: Fakultät für Chemie und Pharmazie
... Although non-viral gene delivery could up to now not make the breakthrough for pDNA delivery, the long experience in non- viral gene delivery helped providing several promising ...
109
A sight on the current nanoparticle based gene delivery vectors
... ful non-viral gene delivery ...other vectors (viral or nonviral), show good gene delivery properties especially when incorporated in the colloidal particulate systems ...other ...
9
Construction and Characterization of an in-vivo Linear Covalently Closed DNA Vector Production System
... DNA vectors need to rapidly cross the plasma membrane of target ...DNA vectors with synthetic nanoparticles to form a structure similar to the plasma membrane [2] or receptor- mediated endocytosis; ...while ...
13
Supramolecular Assemblies of Peptides or Nucleopeptides for Gene Delivery
... evolved vectors for gene ...of viral vectors, such as immunogenicity, researchers have focused on the development of non-viral vectors, especially virus-like ...virus-like ...
10
Advanced therapies for the treatment of hemophilia: future perspectives
... and gene therapy —based on viral (lentiviral and adeno- associated) vectors with improved transfection efficacy and immunogenic properties, or non-viral vectors— may be pointing ...
9
Immunogenicity of Cytopathic and Noncytopathic Viral Vectors
... ated RV strain (38) that is neither cytolytic nor apoptogenic in our hands. Several options were open to us in the engineering of the paired viruses, particularly with respect to positioning of inserted genes. ...
8
Adenoviruses in Gene Therapy A Review
... adenoviral vectors Recently, "gutless" adenoviral vectors - vectors that are devoid of all viral-protein-coding DNA sequences-have been developed ...the viral genes required for ...
5
Sendai F/HN Viroplexes for Efficient Transfection of Leukemic T Cells
... Purpose: Most chemical transfection reagents are ineffective for the transfection of cells in suspension, such as leukemic cell and stem cell lineages. We developed two different types of viroplexes, cationic Sendai F/HN ...
9
Adenovirus-Platelet Interaction in Blood Causes Virus Sequestration to the Reticuloendothelial System of the Liver
... associated with isolated platelet and mixed erythrocyte/platelet fractions (data not shown). Isolated erythrocyte and platelet fractions were fixed in 1/2-strength Karnovsky’s fixative for transmission electron ...
6
umi-unc-2665.pdf
... separate vectors where each carries one ...protein gene product is processed into separate bioactive ...both gene products, and utilizes only a small amount of the AAV vector genome, since ...
180
The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.
... package viral RNA derived from an HIV vector and promote the production of virus particles capable of delivering a gene to target ...nef gene, the 39 end of the env gene including the RRE, and ...
8
Intranasal Adenovirus-Vectored Vaccine for Induction of Long-Lasting Humoral Immunity-Mediated Broad Protection against Influenza in Mice
... the viral ion channel protein, were shown to restrict influenza virus replication and reduce morbidity and mor- tality (5–9), M2e is an attractive target for the development of vaccines inducing broad protection ...
11
GENE THERAPY: RECENT DEVELOPMENT IN THE TREATMENT OF VARIOUS DISEASES
... surface marker from other leukocytes harvested from the bone marrow or mobilized peripheral blood of the recipient. Next, they are cultured for 2–4 days in the presence of growth- stimulating cytokines while being ...
10
Clinical Review: Gene based therapies for ALI/ARDS: where are we now?
... for gene-based therapies as it is an acute but relatively transient process [8], requiring short-lived gene expression, obviating the need for repeated therapies and reducing the risk of an adverse ...
12